Search results
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
Zacks via Yahoo Finance· 13 hours agoThe stock is down 0.1% and up 2% over the past one-week and four-week period, respectively, and...
7 Penny Stocks to Sell in June Before They Crash & Burn
InvestorPlace· 5 days agoThe stock market continues to climb. Traders are looking to penny stocks for big upside,...
adidas Superstar Sneakers Aren’t Going Anywhere — Here Are the Best Ones to Buy Now.
Footwear News via Yahoo News· 9 hours agoHowever, today, the shoe remains a staple suited for everyday wear as a top adidas walking shoe. It...
Behind the Scenes of Intellia Therapeutics's Latest Options Trends - Intellia Therapeutics...
Benzinga· 4 days agoIntellia is focused on using this technology to treat genetically defined diseases. It's evaluating multiple...of Intellia Therapeutics Trading volume stands at 742,147, with NTLA's
Charles River (CRL) Advances in T-Cell Therapy With New Alliance
Zacks via Yahoo Finance· 7 days agoCharles River (CRL) and Captain T Cell announced an agreement on plasmid DNA and retrovirus vector...
McDonald’s $5 Meal Deal: 7 Things to Know as New Value Meal Launches
InvestorPlace· 4 days agoMcDonald’s (NYSE:MCD) is in the news today as the fast-food company is preparing to launch a new $5...
Top 5 Small-Cap Biotechnology Stocks for a Stable Portfolio
Zacks via Yahoo Finance· 4 days agoPrime Medicine has an expected revenue and earnings growth rate of more than 100% and 19.2%,...
The best sales to shop today: Outdoor Voices, Google, Solawave and more
CNN via Yahoo News· 4 days agoToday, you’ll find a deal on a Drybar Buttercup, a discounted Google Pixel 7 Pro and savings on an...
CRISPR Therapeutics Stock (NASDAQ:CRSP): Will It Take Off Anytime Soon?
TipRanks via Yahoo Finance· 5 days agoDespite my optimism about the long-term prospects of curative gene therapy and CRISPR Therapeutics...
Qiagen Lays out Four-Year Plan to Achieve 7 Percent CAGR
GenomeWeb News· 6 days agoAt the New York Stock Exchange on Tuesday, Qiagen guided analysts through a focused growth investment case aimed at maintaining a 7 percent compound annual growth rate at ...